Physician profile
Joseph W Greene
NPI 1356469696
$580,545.34
in general payments reported to CMS, 2019-2025
29 companies · $144K in 2025
The $144K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99K · 2020: $63K · 2021: $86K · 2022: $36K · 2023: $64K · 2024: $89K · 2025: $144K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $259K · Travel and Lodging: $32K · Food and Beverage: $5,967 · Royalty Or License: $48.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $259,237.50 |
| Travel and Lodging | $31,639.49 |
| Food and Beverage | $5,967.30 |
| Royalty Or License | $48.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $308,445.81 | 2021-2025 | Gmk Sphere, Gmk Revision, Myknee |
| Zimmer Biomet Holdings, INC. | $173,259.20 | 2019-2021 | |
| Globus Medical, INC. | $57,056.28 | 2020-2025 | Actify, Actify 3d |
| Smith+Nephew, INC. | $35,394.83 | 2019-2024 | Pico 7, Pico 14, Renasys Touch |
| Medtronic USA, INC. | $2,513.55 | 2019 | |
| Heraeus Medical, LLC. | $1,400.00 | 2020 | |
| Arthrex, INC. | $1,000.00 | 2019 | |
| Stryker Corporation | $302.68 | 2019-2020 | |
| Pacira Therapeutics, INC. | $289.88 | 2019-2021 | |
| Osteoremedies, LLC | $155.53 | 2019 | |
| Kci USA, INC. | $136.87 | 2019-2021 | |
| Encore Medical, Lp | $129.87 | 2021 | |
| Integrity Orthopaedics, INC. | $74.72 | 2024 | Integrity Orthopaedics |
| Heron Therapeutics, INC. | $62.45 | 2025 | Zynrelef |
| Medtronic, INC. | $51.98 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $43.28 | 2025 | |
| Dynasplint Systems INC. | $38.23 | 2021 | |
| Innovation Technologies INC | $29.97 | 2021 | |
| Ethicon US, LLC | $24.12 | 2019 | |
| Bioventus LLC | $19.86 | 2019 | |
| Eagle Pharmaceuticals, INC. | $19.03 | 2022 | |
| Acacia Pharma INC | $18.68 | 2021 | |
| Depuy Synthes Sales INC. | $12.91 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.65 | 2019 | |
| Flowonix Medical Incorporated | $11.61 | 2019 | |
| Alpha Orthopedic Systems | $11.21 | 2019 | |
| Horizon Therapeutics Plc | $11.16 | 2019 | |
| Zyla Life Sciences, INC. | $11.03 | 2020 | |
| Orthofix Medical, INC. | $7.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Greene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.